Caroline Loew's most recent trade in Mural Oncology plc was a trade of 12,531 Ordinary Shares done at an average price of $2.4 . Disclosure was reported to the exchange on July 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mural Oncology plc | Caroline Loew | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.43 per share. | 07 Jul 2025 | 12,531 | 293,059 | - | 2.4 | 30,475 | Ordinary Shares |
| Mural Oncology plc | Caroline Loew | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 134,225 | 134,225 | - | - | Stock Option (right to buy) | |
| Mural Oncology plc | Caroline Loew | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 72,275 | 309,903 | - | 0 | Ordinary Shares | |
| Mural Oncology plc | Caroline Loew | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.36 per share. | 03 Mar 2025 | 4,313 | 305,590 | - | 3.4 | 14,492 | Ordinary Shares |
| Mural Oncology plc | Loew Caroline | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 17 Dec 2024 | 2,763 | 237,628 | - | 3.4 | 9,394 | Ordinary Shares |
| Mural Oncology plc | Caroline Loew | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.91 per share. | 08 Jul 2024 | 12,531 | 240,391 | - | 2.9 | 36,465 | Ordinary Shares |
| eFFECTOR Therapeutics Inc | Caroline M. Loewy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 67,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 49,245 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 32,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 30,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 27,705 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 25,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 16,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 15,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 14,010 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 7,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Mural Oncology plc | Caroline Loew | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 90,025 | 90,025 | - | - | Stock Option (right to buy) | |
| Mural Oncology plc | Caroline Loew | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 48,475 | 252,922 | - | 0 | Ordinary Shares | |
| eFFECTOR Therapeutics Inc | M. Loewy Caroline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2024 | 2,000 | 2,000 | - | - | Stock Option (Right to Buy) | |
| Cymabay Therapeutics Inc | Loewy M. Caroline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 14,010 | 14,010 | - | - | Stock Option (right to buy) | |
| Mural Oncology plc | Caroline Loew | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 379,690 | 379,690 | - | - | Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 67,000 | 67,000 | - | - | Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Caroline M. Loewy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 32,000 | 32,000 | - | - | Stock Option (right to buy) |